CIK 0001501989
- Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273521219
- Phone
- +1 650-515-3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-17 | McCarthy Sean A. CEO | Sale 10b5-1 | −118,969 | $6.42 | $764K | 1,078,922 |
| 2026-02-02 | McCarthy Sean A. CEO | Grant or award | +210,000 | 1,197,891 | ||
| 2026-02-02 | McCarthy Sean A. CEO | Grant or award · Stock Option (Right to Buy) | +980,000 | 980,000 | ||
| 2025-11-06 | McCarthy Sean A. CEO | Exercise or conversion 10b5-1 | +101,793 | $1.59 | $162K | 1,191,477 |
| 2025-11-06 | McCarthy Sean A. CEO | Sale 10b5-1 | −101,793 | $4.54 | $462K | 1,089,684 |
| 2025-11-06 | McCarthy Sean A. CEO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −101,793 | 348,207 | ||
| 2025-11-06 | McCarthy Sean A. CEO | Sale 10b5-1 | −101,793 | $4.54 | $462K | 987,891 |
| 2025-09-26 | McCarthy Sean A. CEO | Grant or award · Stock Option (Right to Buy) | +570,000 | 570,000 | ||
| 2025-09-26 | McCarthy Sean A. CEO | Grant or award · Performance Stock Units (PSUs) | +285,000 | 285,000 | ||
| 2025-06-16 | McCarthy Sean A. CEO | Sale | −55,511 | $2.69 | $149K | 1,089,684 |
| 2025-06-13 | McCarthy Sean A. CEO | Exercise or conversion | +150,000 | 1,145,195 | ||
| 2025-06-13 | McCarthy Sean A. CEO | Exercise or conversion · Performance Stock Units | −150,000 | 0 | ||
| 2025-03-18 | McCarthy Sean A. CEO | Sale | −37,656 | $0.60 | $23K | 995,195 |
| 2025-02-04 | McCarthy Sean A. CEO | Grant or award | +180,000 | 837,851 | ||
| 2025-02-04 | McCarthy Sean A. CEO | Grant or award | +195,000 | 1,032,851 | ||
| 2025-02-04 | McCarthy Sean A. CEO | Grant or award · Stock Option (Right to Buy) | +800,000 | 800,000 | ||
| 2025-02-04 | McCarthy Sean A. CEO | Grant or award · Stock Option (Right to Buy) | +390,000 | 390,000 | ||
| 2024-08-20 | McCarthy Sean A. CEO | Exercise or conversion | +37,500 | 671,749 | ||
| 2024-08-20 | McCarthy Sean A. CEO | Sale | −13,898 | $1.23 | $17K | 657,851 |
| 2024-08-20 | McCarthy Sean A. CEO | Exercise or conversion · Performance Stock Units (PSUs) | −37,500 | 0 |
Page 1 of 9 · 177 trades